Unique ID issued by UMIN | C000000028 |
---|---|
Receipt number | R000000044 |
Scientific Title | (Olmesartan and Valsartan Anti-atherosclerosis Trial in Patients with Mild-Hypertension: Using Three-dimensional serial IVUS)Study |
Date of disclosure of the study information | 2006/04/01 |
Last modified on | 2013/03/19 13:37:39 |
(Olmesartan and Valsartan Anti-atherosclerosis Trial in Patients with Mild-Hypertension: Using Three-dimensional serial IVUS)Study
OVATION Study
(Olmesartan and Valsartan Anti-atherosclerosis Trial in Patients with Mild-Hypertension: Using Three-dimensional serial IVUS)Study
OVATION Study
Japan |
stable angina pectoris with mild hypertension
Cardiology |
Others
NO
By using three-dimensional (3D) intravascular ultrasound (IVUS), we assess if long-term olmesartan therapy just after percutaneous coronary intervention reduces coronary plaques in patients with stable angina pectoris with mild hypertension, compared with valsartan.
Safety,Efficacy
nominal changes in % plaque volumes by three-dimensional intravascular ultrasound at 6-8 months follow-up after percutaneous coronary intervention
(IMT)
change from baseline in mean IMT after 6-8 months
(E/A)
change from baseline in E/A after 6-8 months by echocardiography
(laboratory test)
hs-CRP, adiponectine, aldosterone, renin, oxLDL, HOMA-R, TC, TG, LDL-C, HDL-C, etc
Interventional
Parallel
Randomized
Open -but assessor(s) are blinded
Active
2
Treatment
Medicine |
1) Olmesartan
2) Valsartan
20 | years-old | <= |
Not applicable |
Male and Female
Patients with mild hypertension, who have been treated with statins more than 8 weeks before the randomization
(non-lesion related items)
1)Patients with acute coronary syndrome
2)Previous history of Q myocardial infarction within 4 weeks before the randomization
3)Low left ventricular(LV) function(LV ejection fraction < 45%)
4)Patients with renal failure(serum creatinine > 3.0mg)
5)Patients who are treated with angiotensin converting enzyme inhibitor or receptor blocker, or aldosterone receptor blocker at randomization
(lesion related items)
1)chronic total coronary artery occlusion
2)lesions on bypass grafts
3)unsuccessful stent implantation (stenosis > 50% after PCI)
4)lesions with prior atheroablative procedures before stent implantation
5)lesions implanted with multiple stents
6)left main trunk lesions
7)lesions on small vessels(reference diameter < 2.0 mm)
8)calcified lesions, which preclude accurate quantification of IVUS imaging
200
1st name | |
Middle name | |
Last name | Toyoaki Murohara |
Nagoya University Graduate School of Medicine
The Department of Cardiology
65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan
1st name | |
Middle name | |
Last name | Hideki Ishii |
Nagoya University Graduate School of Medicine
The Department of Cardiology
The Department of Cardiology, Nagoya University Graduate School of Medicine
The Department of Cardiology, Nagoya University Graduate School of Medicine
Self funding
NO
2006 | Year | 04 | Month | 01 | Day |
Unpublished
Completed
2005 | Year | 06 | Month | 16 | Day |
2005 | Year | 07 | Month | 01 | Day |
2012 | Year | 12 | Month | 01 | Day |
2005 | Year | 07 | Month | 27 | Day |
2013 | Year | 03 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000044
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |